MMB-2201

5F-AMB-PICA.svg

MMB-2201 is a synthetic cannabinoid that belongs to the indole-3-carboxamide family. It is a potent agonist of the cannabinoid receptors, specifically the CB1 and CB2 receptors. MMB-2201 is often used in scientific research to study the effects of cannabinoids on the human body and the endocannabinoid system.

Chemical Structure and Properties

MMB-2201 has a chemical structure that includes an indole core, which is a common feature among many synthetic cannabinoids. The full chemical name of MMB-2201 is (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthoyl)methanone. The presence of a fluoropentyl chain and a naphthoyl group are characteristic features that contribute to its high affinity for cannabinoid receptors.

Pharmacology

MMB-2201 acts as a full agonist at both the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a crucial role in regulating various physiological processes, including pain sensation, mood, appetite, and memory. The activation of these receptors by MMB-2201 can lead to a range of effects, both therapeutic and adverse.

Legal Status

The legal status of MMB-2201 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important to consult local regulations to determine the legality of MMB-2201 in a specific area.

Potential Risks and Side Effects

As with other synthetic cannabinoids, the use of MMB-2201 can pose significant health risks. Adverse effects may include tachycardia, hypertension, anxiety, paranoia, and hallucinations. In severe cases, it can lead to acute kidney injury and other life-threatening conditions. Due to these risks, the recreational use of MMB-2201 is strongly discouraged.

Research Applications

MMB-2201 is primarily used in scientific research to better understand the endocannabinoid system and the pharmacological effects of synthetic cannabinoids. Studies involving MMB-2201 can provide valuable insights into the development of new therapeutic agents for various medical conditions.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• CB1 receptor
• CB2 receptor

External Links

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian